Necessity is the mother of invention: An ingenious method for leukocyte-targeted delivery of siRNA in stabilized nanoparticles demonstrates a role of cyclin D1 in inflammation

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)

Abstract

(Figure Presented) Leukocyte-targeted delivery of siRNA in stabilized nanoparticles: This Highlight article summarizes elegantly designed targeted nanoparticles that can be administered systemically to deliver siRNA for cyclin D1 to specific leukocyte subsets. Silencing of cyclin D1 in this way can reverse experimentally induced colitis in mice.

Original languageEnglish
Pages (from-to)1024-1025
Number of pages2
JournalChemMedChem
Volume3
Issue number7
DOIs
Publication statusPublished - Jul 14 2008

Keywords

  • Cyclin D1
  • Inflammation
  • Nanoparticles
  • RNA interference
  • Systemic administration

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Necessity is the mother of invention: An ingenious method for leukocyte-targeted delivery of siRNA in stabilized nanoparticles demonstrates a role of cyclin D1 in inflammation'. Together they form a unique fingerprint.

Cite this